High Expression of NRF2 Is Associated with Increased Tumor-Infiltrating Lymphocytes and Cancer Immunity in ER-Positive/HER2-Negative Breast Cancer

SIMPLE SUMMARY: The clinical relevance of Nuclear factor erythroid 2-Related Factor 2 (NRF2) in human breast cancer remains unclear. A total of 5443 breast cancer patients with transcriptomic profile were analyzed for the clinical relevance of NRF2 expression, including cancer aggressiveness, immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshi, Masanori, Angarita, Fernando A., Tokumaru, Yoshihisa, Yan, Li, Matsuyama, Ryusei, Endo, Itaru, Takabe, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766649/
https://www.ncbi.nlm.nih.gov/pubmed/33371179
http://dx.doi.org/10.3390/cancers12123856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766649/
https://www.ncbi.nlm.nih.gov/pubmed/33371179
http://dx.doi.org/10.3390/cancers12123856

Ejemplares similares